Fresenius SE & Co. KGaA (ETR:FRE)

Market Cap	26.58B
Revenue (ttm)	22.45B
Net Income (ttm)	1.14B
Shares Out	563.24M
EPS (ttm)	2.03
PE Ratio	24.32
Forward PE	13.02
Dividend	1.00 (2.12%)
Ex-Dividend Date	n/a

Volume	1,085,913
Average Volume	748,596
Open	47.25
Previous Close	46.94
Day's Range	47.00 - 47.64
52-Week Range	31.60 - 50.74
Beta	0.92
RSI	43.16
Earnings Date	Nov 5, 2025

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly know...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1912
• Employees: 176,486
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: FRE